TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.

Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.

Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.

We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.

BNP Paribas

Bpifrance

CM-CIC Capital Prive

Sofinnova Partners

European Investment Fund

Omnes Capital

Karista

Cathay Capital

Cathay Health

Crédit Mutuel Innovation

Mérieux Equity Partners

Merieux Developpement

Fonds Stratégique d'Investissement

IBD Ventures

TISSIUM

Mölnlycke France is a competitor of TISSIUM in the medical technology sector, offering solutions for tissue reconstruction.

Mölnlycke France

GMED is a competitor of TISSIUM in the medical technology sector, providing products and solutions for tissue reconstruction.

GMED

SURGIVISIO competes with TISSIUM in the medical technology sector, offering solutions for tissue reconstruction.

SURGIVISIO

Johnson & Johnson is a major player in the medical devices industry, with innovation areas that may overlap with tissue reconstruction and implants.

Johnson & Johnson

Medtronic is a leading company in the medical devices industry, with potential innovation areas related to tissue reconstruction and implants.

Medtronic

Geistlich Pharma is involved in the innovation of tissue reconstruction implants and may compete with TISSIUM in this area.

Geistlich Pharma

Albemarle is a company with innovation areas that may intersect with tissue reconstruction and implants in the medical devices industry.

Albemarle

EW Healthcare Partners is an investment firm that may have interests in companies related to tissue reconstruction and implants in the medical devices industry.

EW Healthcare Partners

B. Braun is a company with activities in the medical devices industry, potentially including innovation areas related to tissue reconstruction and implants.

B. Braun

Tissium is a biotechnology company focused on the development of biomorphic programmable polymers for tissue reconstruction. Their approach aims to provide solutions that mimic the native environment of tissues, potentially revolutionizing the field of regenerative medicine.

Tissium

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 7:37 AM	a34ecc5f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 14, 2024 7:37 AM	b9eba2aa
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:TISSIUM

Tissium